Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 3 trial of Atacicept for IgA Nephropathy (IGAN)

Next Previous
Search
Trial Profile

Phase 3 trial of Atacicept for IgA Nephropathy (IGAN)

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 18 Nov 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atacicept (Primary)
  • Indications Autoimmune disorders; Glomerulonephritis; IgA nephropathy
  • Focus Registrational; Therapeutic Use
  • Acronyms PIONEER
  • Sponsors Vera Therapeutics

    • Most Recent Events

    • 11 Nov 2024 According to a Vera Therapeutics media release, company will present initial data from PIONEER study in 2025 and NEPTUNE Match, in partnership with Vera Therapeutics, will inform participants about the PIONEER study. PIONEER expands atacicept research into autoimmune kidney diseases, including IgAN, pMN, FSGS, and MCD, targeting anti-PLA2R and anti-nephrin antibodies. The program supports informed decisions about clinical trial participation.
    • 26 Oct 2024 According to a Vera Therapeutics media release, trial is divided in 2 cohorts Expanded IgAN populations and Anti-PLA2R and anti-nephrin podocytopathies.
    • 02 Oct 2024 According to a Vera Therapeutics media release, PIONEER study expands the investigation of atacicept into a broad definition of IgA nephropathy and into multiple autoimmune glomerular diseases.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top